| 4.66 0.44 (10.43%) | 06-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.72  |
1-year : | 6.68 |
| Resists | First : | 4.89 |
Second : | 5.72 |
| Pivot price | 4 |
|||
| Supports | First : | 4.06 |
Second : | 3.55 |
| MAs | MA(5) : | 4.19 |
MA(20) : | 4.01 |
| MA(100) : | 3.25 |
MA(250) : | 5.87  |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 84 |
D(3) : | 66.3 |
| RSI | RSI(14): 66 |
|||
| 52-week | High : | 12.06 | Low : | 2.09 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ EVH ] has closed Bollinger Bands are 5.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.9 - 4.94 | 4.94 - 4.96 |
| Low: | 4.19 - 4.23 | 4.23 - 4.25 |
| Close: | 4.61 - 4.67 | 4.67 - 4.71 |
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Mon, 08 Jun 2026
[Form 4] Evolent Health, Inc. Insider Trading Activity - Stock Titan
Mon, 08 Jun 2026
Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant - Stock Titan
Mon, 08 Jun 2026
Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units - Stock Titan
Mon, 08 Jun 2026
Evolent Health (EVH) director receives 41,096 restricted stock units award - Stock Titan
Fri, 05 Jun 2026
Evolent Health Shareholders Approve Proposals at 2026 Meeting - The Globe and Mail
Wed, 03 Jun 2026
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 - Quantisnow
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 112 (M) |
| Shares Float | 94 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 100.9 (%) |
| Shares Short | 14,940 (K) |
| Shares Short P.Month | 16,200 (K) |
| EPS | -4.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.51 |
| Profit Margin | -26.3 % |
| Operating Margin | -2.1 % |
| Return on Assets (ttm) | -0.5 % |
| Return on Equity (ttm) | -65.2 % |
| Qtrly Rev. Growth | 2.5 % |
| Gross Profit (p.s.) | 3.38 |
| Sales Per Share | 16.8 |
| EBITDA (p.s.) | 0.66 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 33 (M) |
| Levered Free Cash Flow | 53 (M) |
| PE Ratio | -1 |
| PEG Ratio | 1.9 |
| Price to Book value | 1.32 |
| Price to Sales | 0.27 |
| Price to Cash Flow | 15.74 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|